FDA Approves Bemotrizinol, Expanding U.S. Sunscreen Ingredient Options
The U.S. Food and Drug Administration (FDA) has approved bemotrizinol for use in American sunscreens, marking the first new active ingredient approval since the 1990s. Bemotrizinol is a chemical compound that provides broad-spectrum protection against UVA and UVB rays. It has been used in Europe and Asia for decades and is known for its stability and low absorption into the body. The approval process was expedited under the CARES Act, which aims to streamline the approval of over-the-counter drugs. Health and Human Services Secretary Robert F. Kennedy Jr. stated that this move will enhance competition and consumer confidence in sunscreen products. 
